CLIP2 as radiation biomarker in papillary thyroid carcinoma

Area of Science:

• Oncology
• Genetics
• Radiation Biology

Background:

• The Chernobyl accident led to a significant rise in childhood papillary thyroid carcinoma (PTC).
• Previous studies linked radioiodine fallout exposure to specific genetic alterations, including a gain on chromosome 7q11.23 and CLIP2 mRNA overexpression in PTC.
• CLIP2's role as a potential radiation marker for PTC classification requires investigation.

Purpose of the Study:

• To investigate CLIP2 as a radiation marker for classifying papillary thyroid carcinoma (PTC) cases.
• To develop and validate a standardized workflow for determining CLIP2-positive and CLIP2-negative PTC.
• To explore CLIP2's functional role in radiation-associated PTC development.

Main Methods:

• Validated CLIP2 overexpression at the protein level using immunohistochemistry (IHC) and digital image analysis.
• Developed a standardized workflow combining IHC scoring and genomic copy number status for CLIP2 classification.
• Investigated three independent PTC cohorts (n=148 total) to assess workflow robustness.
• Reconstructed the CLIP2 gene regulatory network using mRNA expression data.

Main Results:

• Confirmed radiation-associated CLIP2 overexpression at the protein level (P=0.0149).
• Achieved high sensitivity and specificity in classifying PTCs as CLIP2-positive or -negative across all cohorts.
• Identified CLIP2's potential involvement in apoptosis, MAPK signaling, and genomic instability through network analysis.

Conclusions:

• A robust and validated workflow for classifying PTCs based on CLIP2 status (positive/negative) has been established.
• CLIP2 serves as a reliable marker for radiation-associated PTC.
• CLIP2's interactome suggests its involvement in key carcinogenic pathways relevant to radiation exposure.